1. Context: Antimicrobial Resistance as a Public Health Concern
- Antimicrobial Resistance (AMR) occurs when microorganisms such as bacteria and fungi evolve to resist the effects of medicines designed to kill them, threatening the effectiveness of antibiotics.
- In India, irrational and indiscriminate use of antibiotics in humans, animals, and agriculture has accelerated the rise of AMR, leading to reduced treatment efficacy for common infections like pneumonia, UTIs, and bloodstream infections.
- PM Narendra Modi highlighted AMR in his 129th Mann Ki Baat (Dec 28, 2025), marking a critical step in mainstreaming awareness and public responsibility on the issue.
The governance logic: Raising public awareness directly influences health-seeking behaviour, essential for reducing self-medication and antibiotic misuse. Ignoring AMR awareness risks escalating treatment failures and health system burdens.
2. National and Global Policy Frameworks
- India’s response is structured around the National Action Plan on AMR (2025–29), focusing on surveillance, awareness, research, and stewardship.
- The WHO Global Action Plan (2015) provides a global framework with five objectives: awareness, surveillance and research, infection reduction, optimized antimicrobial use, and sustainable investment in new medicines and diagnostics.
- Regulatory interventions, such as the ban on colistin as a growth promoter, complement these frameworks by addressing misuse in agriculture and veterinary practices.
- Key Policy Measures:
- NAP-AMR (2025–29) – India-specific roadmap
- Colistin ban – Preventing AMR from livestock use
- Alignment with WHO GLASS objectives
The governance logic: Policy frameworks establish institutional and legal mechanisms to combat AMR. Weak implementation or gaps in regulation could allow continued rise in resistance and undermine health security.
3. Surveillance and Data Challenges
- The National AMR Surveillance Network (NARS-Net), established in 2013, monitors nine priority bacterial pathogens and some fungi across sentinel medical college laboratories.
- Current coverage is urban- and tertiary-centric, with 41 sites in 31 States/UTs reporting to WHO GLASS for 2023. Non-urban and private sector data remain largely unrepresented.
- Experts recommend expanding surveillance to primary and secondary care centers and private hospitals to generate a representative national dataset.
- Impacts:
- Limited surveillance may overestimate resistance if urban tertiary cases dominate the data
- Non-urban populations remain underrepresented, affecting policy targeting
- Robust surveillance informs resource allocation, public health interventions, and AMR trend analysis
The governance logic: Comprehensive surveillance ensures informed policy decisions and resource prioritization. Ignoring coverage gaps risks misrepresenting the national AMR burden.
4. Public Awareness and Behavioural Interventions
- PM Modi’s Mann Ki Baat addressed indiscriminate self-medication and casual antibiotic use, translating technical AMR risks into actionable public guidance.
- Public understanding of antibiotic stewardship is critical to reduce misuse and slow AMR progression.
- Awareness campaigns complement structural interventions, fostering responsible health-seeking behaviour and adherence to prescription norms.
- Impacts:
- Behavioural change can significantly reduce unnecessary antibiotic consumption
- Citizen engagement amplifies policy effectiveness beyond clinical settings
- Public awareness bridges the gap between laboratory evidence and community practice
The governance logic: Population-level interventions rely on informed behaviour. Neglecting citizen awareness undermines systemic AMR containment strategies.
5. One Health Approach and Integrated Solutions
- AMR is a multisectoral challenge, requiring coordination between human health, animal health, and environmental management.
- One Health approaches integrate these domains, addressing drivers like livestock antibiotic use, environmental contamination, and clinical misuse.
- Cross-sectoral strategies enhance effectiveness of national policies, surveillance, and public education initiatives.
The governance logic: Integrated interventions reduce cross-sector AMR transmission. Failure to adopt One Health approaches risks isolated, ineffective responses and persistent resistance reservoirs.
6. Way Forward and Strategic Imperatives
- Expanding surveillance networks to include non-urban and private healthcare sectors.
- Strengthening public awareness campaigns to instill responsible antibiotic use.
- Promoting research and innovation for new antibiotics, diagnostics, and vaccines.
- Implementing the One Health approach across sectors to curb AMR comprehensively.
- Strategic Priorities:
- Nationwide AMR surveillance expansion
- Behavioural interventions through mass media and public campaigns
- Investment in R&D for antimicrobial innovation
- Coordinated governance integrating human, animal, and environmental health
The governance logic: Coordinated, multi-pronged strategies convert awareness and policy into measurable AMR reduction. Ignoring systemic integration risks continued escalation and global health implications.
Conclusion
- Antimicrobial Resistance poses a looming health crisis in India, requiring urgent public, clinical, and policy action.
- PM Modi’s public address represents a pivotal step in mainstreaming awareness, but surveillance expansion, policy enforcement, and integrated One Health approaches are critical to control AMR.
- Strategic, inclusive, and coordinated action over the next decade is essential to prevent a regression to a pre-antibiotic era and safeguard public health.
